Between now and Oct. 31, the US Food and Drug Administration is accepting public comments on how cannabis should be classified under international drug treaties.

“These comments will be considered in preparing a response from the United States to the World Health Organization (WHO) regarding the abuse liability and diversion of these drugs,” wrote FDA’s associate commissioner for policy, Leslie Kux.

See the original article at Leafly